<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02076321</url>
  </required_header>
  <id_info>
    <org_study_id>1207111</org_study_id>
    <nct_id>NCT02076321</nct_id>
  </id_info>
  <brief_title>The Effect of NSAID Use in the Acute Phase of Skeletally Immature Bone Healing: A Prospective Study</brief_title>
  <official_title>The Effect of NSAID Use in the Acute Phase of Skeletally Immature Bone Healing: A Prospective Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Missouri-Columbia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Missouri-Columbia</source>
  <brief_summary>
    <textblock>
      Non-steroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen, are excellent medications
      for providing pain control in children with fractures or those who have surgery to correct
      bony deformity requiring the bone to be cut (osteotomy) and realigned. There is some data to
      suggest that these types of medications can adversely affect bone healing in adult patients
      with broken bones or those having spine fusion surgery. There is little data with regard to
      how these medications effect bone healing in children. With this project, the investigators'
      goal is to determine if NSAIDs delay or otherwise adversely effect bone healing and to
      demonstrate that these medications adequately control pain in children with broken bones or
      those who have had an osteotomy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Non-steroidal anti-inflammatory drugs (NSAIDs) are effective in controlling both
      post-operative pain and pain associated with orthopaedic injuries, particularly in the
      pediatric population. Additionally, use of NSAIDs for pain control in this setting avoids the
      use of narcotic pain medications, the adverse effects of which are well known.

      Recent research has suggested a possible association between use of NSAIDs and impaired
      fracture healing in the skeletally mature, or adult, population. Several adult mammal studies
      have demonstrated inhibition of bony repair with administration of NSAIDs. Yet, other adult
      animal studies have failed to find the same effect. Clinical data in the adult population is
      similarly conflicted, with some studies showing an inhibition of bone healing after posterior
      spinal fusion, while a larger study found no correlation. The data investigating the effects
      of NSAID use in adults after fracture or osteotomy is even less clear with some studies
      demonstrating higher rates of non-union with NSAID administration and others finding no
      significant effect on bone healing.

      The research investigating these outcomes in the skeletally immature population is limited;
      one study compared administration of ketorolac versus normal saline for 7, 14 and 21 days in
      a juvenile rat model with a stabilized tibia fracture. They found no significant difference
      in strength, stiffness or histological characteristics of fracture callus between the two
      groups. Clinical retrospective studies of the pediatric population with regard to use of
      NSAIDs after posterior spinal fusion have failed to reproduce findings of inhibitory effects
      on bone healing. Similarly, two retrospective studies found no cases of delayed union or
      non-union in pediatric patients who received perioperative ketorolac around the time of
      operative fixation of fractures, or osteotomy. Given these results, the way in which and the
      degree to which NSAIDs perturb the inflammatory mileu during the acute phase of healing is
      potentially distinct from the effects on bone healing in the skeletally mature.

      There have been no clinical prospective, randomized studies to evaluate the effect, if any,
      that NSAIDs have on bone healing in the skeletally immature patient population. The
      investigators hypothesize that NSAID administration in the acute phase of bone healing,
      whether it be a fracture or osteotomy, will not result in delayed union or non-union as
      compared to patients who take acetaminophen for pain control during this same time period.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 2014</start_date>
  <completion_date type="Actual">November 2016</completion_date>
  <primary_completion_date type="Actual">November 2016</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Compare the Time to Union of Fractures and Osteotomies in Skeletally Immature Patients Administered NSAIDs for Pain Control, Versus Those Administered Acetaminophen for Pain Control.</measure>
    <time_frame>The subject will be enrolled/assessed up to 6 months post-injury/osteotomy.</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">102</enrollment>
  <condition>Fractures</condition>
  <arm_group>
    <arm_group_label>Acetaminophen</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>control group</description>
  </arm_group>
  <arm_group>
    <arm_group_label>NSAID (Ibuprofen)</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Study group</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Acetaminophen</intervention_name>
    <description>acetaminophen for pain control with dose and frequency of 10-15mg/kg/dose, Maximum dose 1000mg. Maximum amount per day: 75mg/kg (not to exceed 4g/day).</description>
    <arm_group_label>Acetaminophen</arm_group_label>
    <other_name>Tylenol</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ibuprofen</intervention_name>
    <description>ibuprofen for pain control with dose and frequency 4-10mg/kg/dose. Maximum of 40mg/kg/day, not to exceed 3,200mg/day. Maximum one-time dose of 800mg.</description>
    <arm_group_label>NSAID (Ibuprofen)</arm_group_label>
    <other_name>Advil</other_name>
    <other_name>Motrin</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  • Male aged 16 years or less or female aged 14 years or less

               -  Open physis on radiographs

               -  Fracture undergoing closed treatment or operative treatment or patient undergoing
                  elective osteotomy

        Exclusion Criteria:

          -  • Regular use of NSAIDs

               -  Allergy to NSAIDs

               -  Inability to take breakthrough medications due side effects or allergy

               -  Systemic illness

               -  Renal impairment

               -  Liver disease

               -  Polytrauma

               -  Uncontrolled diabetes

               -  Regular use of corticosteroids

               -  History of any skeletal dysplasia

               -  History of neuromuscular disorder

               -  History of bleeding disorder

               -  History of liver disorder

               -  Pathologic fracture

               -  Closed physes

               -  Male greater than 16 years old

               -  Female greater than 14 years old

               -  Pregnant or possibly pregnant females based on report and last menstrual period
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>16 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Daniel G Hoernschemeyer, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Missouri-Columbia</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Missouri Health System</name>
      <address>
        <city>Columbia</city>
        <state>Missouri</state>
        <zip>65212</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 19, 2014</study_first_submitted>
  <study_first_submitted_qc>February 27, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 3, 2014</study_first_posted>
  <results_first_submitted>January 22, 2018</results_first_submitted>
  <results_first_submitted_qc>March 2, 2018</results_first_submitted_qc>
  <results_first_posted type="Actual">April 2, 2018</results_first_posted>
  <last_update_submitted>March 2, 2018</last_update_submitted>
  <last_update_submitted_qc>March 2, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 2, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Missouri-Columbia</investigator_affiliation>
    <investigator_full_name>Daniel Hoernschemeyer</investigator_full_name>
    <investigator_title>Orthopaedic Surgeon</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acetaminophen</mesh_term>
    <mesh_term>Ibuprofen</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Acetaminophen</title>
          <description>control group
Acetaminophen: acetaminophen for pain control with dose and frequency of 10-15mg/kg/dose, Maximum dose 1000mg. Maximum amount per day: 75mg/kg (not to exceed 4g/day).</description>
        </group>
        <group group_id="P2">
          <title>NSAID (Ibuprofen)</title>
          <description>Study group
Ibuprofen: ibuprofen for pain control with dose and frequency 4-10mg/kg/dose. Maximum of 40mg/kg/day, not to exceed 3,200mg/day. Maximum one-time dose of 800mg.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="51"/>
                <participants group_id="P2" count="51"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="46"/>
                <participants group_id="P2" count="49"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="5"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Acetaminophen</title>
          <description>control group
Acetaminophen: acetaminophen for pain control with dose and frequency of 10-15mg/kg/dose, Maximum dose 1000mg. Maximum amount per day: 75mg/kg (not to exceed 4g/day).</description>
        </group>
        <group group_id="B2">
          <title>NSAID (Ibuprofen)</title>
          <description>Study group
Ibuprofen: ibuprofen for pain control with dose and frequency 4-10mg/kg/dose. Maximum of 40mg/kg/day, not to exceed 3,200mg/day. Maximum one-time dose of 800mg.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="51"/>
            <count group_id="B2" value="51"/>
            <count group_id="B3" value="102"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="51"/>
                    <measurement group_id="B2" value="51"/>
                    <measurement group_id="B3" value="102"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="7.44" lower_limit="2" upper_limit="16"/>
                    <measurement group_id="B2" value="7.67" lower_limit="1.5" upper_limit="16"/>
                    <measurement group_id="B3" value="7.56" lower_limit="1.5" upper_limit="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="19"/>
                    <measurement group_id="B2" value="23"/>
                    <measurement group_id="B3" value="42"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="32"/>
                    <measurement group_id="B2" value="28"/>
                    <measurement group_id="B3" value="60"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="51"/>
                    <measurement group_id="B2" value="51"/>
                    <measurement group_id="B3" value="102"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Compare the Time to Union of Fractures and Osteotomies in Skeletally Immature Patients Administered NSAIDs for Pain Control, Versus Those Administered Acetaminophen for Pain Control.</title>
        <time_frame>The subject will be enrolled/assessed up to 6 months post-injury/osteotomy.</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Acetaminophen</title>
            <description>control group
Acetaminophen: acetaminophen for pain control with dose and frequency of 10-15mg/kg/dose, Maximum dose 1000mg. Maximum amount per day: 75mg/kg (not to exceed 4g/day).</description>
          </group>
          <group group_id="O2">
            <title>NSAID (Ibuprofen)</title>
            <description>Study group
Ibuprofen: ibuprofen for pain control with dose and frequency 4-10mg/kg/dose. Maximum of 40mg/kg/day, not to exceed 3,200mg/day. Maximum one-time dose of 800mg.</description>
          </group>
        </group_list>
        <measure>
          <title>Compare the Time to Union of Fractures and Osteotomies in Skeletally Immature Patients Administered NSAIDs for Pain Control, Versus Those Administered Acetaminophen for Pain Control.</title>
          <units>Days</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="51"/>
                <count group_id="O2" value="51"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="41.2" lower_limit="22" upper_limit="84"/>
                    <measurement group_id="O2" value="40.5" lower_limit="19" upper_limit="98"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Acetaminophen</title>
          <description>control group
Acetaminophen: acetaminophen for pain control with dose and frequency of 10-15mg/kg/dose, Maximum dose 1000mg. Maximum amount per day: 75mg/kg (not to exceed 4g/day).</description>
        </group>
        <group group_id="E2">
          <title>NSAID (Ibuprofen)</title>
          <description>Study group
Ibuprofen: ibuprofen for pain control with dose and frequency 4-10mg/kg/dose. Maximum of 40mg/kg/day, not to exceed 3,200mg/day. Maximum one-time dose of 800mg.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="51"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="51"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="51"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="51"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Daniel Hoernschemeyer</name_or_title>
      <organization>University of Missouri, Department of Orthopaedics</organization>
      <phone>(573)882-1351</phone>
      <email>hoernschemeyerd@health.missouri.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

